Saraswati Vaidyanathan Sukumar - Nanotechnology

Author Information

Saraswati Vaidyanathan Sukumar is a prominent researcher affiliated with the Department of Oncology at Johns Hopkins University School of Medicine in Baltimore, Maryland. Her work is highly regarded in the field of oncology, with a specific focus on nanotechnology applications in cancer research.

Research Contributions

Dr. Sukumar has made significant contributions to the understanding and treatment of various cancers, particularly breast cancer. Her recent papers highlight her research on intraductal administration of immunotoxins for eliminating ductal carcinoma in situ, functional antagonism of junctional adhesion molecules in breast cancer, and the development of high-performance methylated DNA markers for cancer detection. Her work extends to the study of tumorigenesis, detection of colon adenocarcinoma, and advancements in automated DNA methylation assays for monitoring treatment responses in metastatic breast cancer.

Aliases

S. Sukumar, Sara Sukumar, Saraswati V. Sukumar, Saraswati Sukumar, S Sukumar, Saraswati Vaidyanathan Sukumar

Publication and Citation Metrics

Citation Count	28,826
h-index	77
Paper Count	362

Publications:

Abstract P5-08-03: Intraductal administration of a Transferrin Receptor-directed immunotoxin eliminates ductal carcinoma in situ in preclinical mammary in-duct (MIND) models of breast cancer

DOI: 10.1158/1538-7445.sabcs21-p5-08-03

Year: 2022

Functional Antagonism of Junctional Adhesion Molecule-A (JAM-A), Overexpressed in Breast Ductal Carcinoma In Situ (DCIS), Reduces HER2-Positive Tumor Progression

DOI: 10.3390/cancers14051303

Year: 2022

CRYβB2 enhances tumorigenesis through upregulation of nucleolin in triple negative breast cancer

DOI: 10.1038/s41388-021-01975-3

Year: 2021

High performance methylated DNA markers for detection of colon adenocarcinoma

DOI: 10.1186/s13148-021-01206-2

Year: 2021

Methylated markers accurately distinguish primary central nervous system lymphomas (PCNSL) from other CNS tumors

DOI: 10.1186/s13148-021-01091-9

Year: 2021

Gene methylation and cytological atypia in random fine needle aspirates for assessment of breast cancer risk: 10-year follow up in average risk women.

DOI: 10.1200/JCO.2021.39.15_SUPPL.10520

Year: 2021

Abstract PS4-03: An automated DNA methylation assay for monitoring treatment response in patients with metastatic breast cancer

DOI: 10.1158/1538-7445.SABCS20-PS4-03

Year: 2021

Intraductal administration of N-methyl-N-nitrosourea as a novel rodent mammary tumor model.

DOI: 10.21037/atm-21-1540

Year: 2021

Automated and rapid detection of cancer in suspicious axillary lymph nodes in patients with breast cancer

DOI: 10.1038/s41523-021-00298-6

Year: 2021

Correction: HIF-1-dependent expression of angiopoietin-like 4 and L1CAM mediates vascular metastasis of hypoxic breast cancer cells to the lungs

DOI: 10.1038/s41388-020-01618-z

Year: 2021

How does temperature affect nanostructures?

How Does RSM Work?

What are Material Defects?

What are High Vacuum Levels?

What are the Mechanisms Behind Thermal Conductivity in Nanomaterials?

What are the Challenges in Developing Nanoscale Resonant Circuits?

How to Prioritize Funding?

What is the Future Outlook for Nanotechnology in Multiplexed Diagnostics?

How are 3D Nano Architectures Created?

Why are Layers of Transistors Important in Nanotechnology?

Partnered Content Networks

Relevant Topics